What is the difference between a CT scan and a PET scan for HER2-Positive Breast Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
CT Scan vs. PET Scan for HER2-Positive Breast Cancer
Great question! These are two different imaging tools that doctors use for different purposes. Let me break down how they work and when each is used.
How They Work Differently
CT Scan (Computed Tomography):
- Uses X-rays to create detailed pictures of the inside of your body
- Shows the structure and anatomy — what organs and tissues look like
- Takes cross-sectional images (like slices) that a computer assembles into a 3D picture
- Very good at showing the size, location, and shape of tumors and lymph nodes
PET Scan (Positron Emission Tomography):
- Uses a radioactive tracer (a special substance injected into your vein) combined with glucose (sugar)
- Shows how active cells are metabolically — which areas are using sugar/energy
- Cancer cells typically use sugar much faster than normal cells, so they "light up" as bright spots on the scan
- Better at detecting cancer activity rather than just showing structure
Key Difference in What They Show
According to NCCN Guidelines for Patients: Invasive Breast Cancer, the important distinction is:
- CT shows anatomy (the physical structure)
- PET shows function (how active the cancer cells are)
This is why doctors sometimes use them together as a PET/CT scan — combining the structural detail of CT with the metabolic activity information from PET.
When Each Is Used for Breast Cancer
CT Scans are typically used for:
- Initial staging (determining how far cancer has spread)
- Checking for spread to lungs, liver, and other organs
- Monitoring treatment response
- Planning radiation therapy
PET Scans may be used for:
- Finding cancer in lymph nodes and distant sites when other imaging is unclear
- Assessing treatment response (seeing if cancer cells are still active)
- Detecting metastatic disease (cancer that has spread)
According to NCCN Guidelines, FDG-PET/CT (which combines both) may be used as an adjunct to or in place of standard staging, and can be performed at the same time as diagnostic CT.
Important Limitations to Know
PET Scan Limitations:
- Not all tumors show up on PET scans
- Not all bright spots are cancer — inflammation or infection can also appear bright
- It's normal for the brain, heart, kidneys, and bladder to show up as bright areas
CT Scan Limitations:
- Uses radiation (though in small amounts)
- May miss very small areas of cancer
For Your HER2-Positive Breast Cancer Specifically
Your oncologist will determine which imaging is most appropriate for YOUR situation based on:
- Whether you're being staged initially or monitored during/after treatment
- Whether there's concern about spread to distant sites
- What other imaging has already been done
- Your specific treatment plan
Questions to Ask Your Oncology Team
- Which imaging test(s) do you recommend for my staging/monitoring, and why?
- Will I need both CT and PET scans, or just one?
- What will these scans help you decide about my treatment?
- How often will I need imaging scans during my treatment?
- Are there any risks or side effects I should know about with these scans?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for HER2-Positive Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: